Mink Therapeutics Inc（INKT）价格预测INKTMink Therapeutics Inc

Alphio's INKT stock price prediction model matches the current Mink Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.47 (+0.81%). The 1-week path is $10.00 (-3.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Mink Therapeutics Inc (INKT) is not a strong buy. The stock is trading at $11.04, which is significantly below its 52-week high of $16.93, indicating a potential for recovery but also suggesting volatility. The RSI is at 61.56, indicating that the stock is nearing overbought territory. Additionally, insider selling has increased by 432.67%, which raises concerns about the confidence of those within the company. The upcoming earnings report on November 13, 2026, could provide further clarity on the company's financial health, but with a current net loss of $3.1 million in Q2 2026, caution is advised.

Mink Therapeutics Inc (INKT) last closed at $10.3900003, gaining +3.38%. These facts feed the 1-day and 1-week INKT price prediction above.